Drug Development With Our CAPRO Platform

CAPRO is a novel class of polymer excipients with tunable physiochemical properties and biodegradation profiles with excellent biocompatibility, which allows us to engineer their properties and functions to a specific application. It provides a seemingly endless diversity in topology and chemistry that provides a crucial advantage over other classes of materials to meet the ever-increasing requirements of new designs of drug delivery formulations.

CAPRO Makes Your Drug Better

The pairing of therapeutic agents to CAPRO polymeric carriers, offers several advantages, including improved drug solubilization, prolonged circulation, superior encapsulation efficacy, enhanced bioavailability, an improved release profile, low toxicity, reduced immunogenicity, controlled release and enhanced safety.

The drug release from any carrier is a complex interaction between drug types/properties, polymer characteristics and in-vivo conditions but CAPRO overcomes many of the limitations associated with other polymer types:

Whether injected, applied to subcutaneous tissue or orally administered, CAPRO allows the modification of the biopharmaceutical and biokinetic behavior of the transported active molecule increasing its efficacy and stability and reduces cytotoxicity on healthy peripheral tissues. It allows a drug to reach its site of action at a particular concentration and enables a constant therapeutic dose range over a sufficiently long period of time to alter the process.

Whether your application for a long acting injectable, subcutaneous applications or oral delivery, CAPRO could be the appropriate tool for solubility, stability and time & distribution-controlled drug delivery across just about any medical discipline.

If you would like to hear more about our CAPRO Drug Delivery Platform and how we can augment your drug development goals, contact us today!